Business Context and Reporting Period
This Form 8-K filing by Hancock Jaffe Laboratories, Inc. (HJLI) reports on the completion of its 2019 Annual Meeting of Stockholders held on December 6, 2019. The registrant is incorporated in Delaware and trades on The NASDAQ Stock Market LLC under the symbol HJLI. The filing details the voting outcomes for director elections and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes and Voting Results
At the Annual Meeting, 11,306,644 shares of the 17,922,129 voting shares entitled to vote were present or represented by proxy. Two proposals were voted upon:
- Proposal 1: Election of Class II Directors
- Matthew M. Jenusaitis: Elected with 7,233,102 shares voted for and 329,589 shares withheld.
- Robert Berman: Elected with 2,320,086 shares voted for and 5,242,605 shares withheld.
- Broker Non-Votes: 3,743,953 shares were recorded as broker non-votes for both nominees.
- Proposal 2: Ratification of Independent Auditor
- Marcum LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2019.
- Voting Results: 11,036,600 shares voted for, 54,103 shares voted against, and 215,941 shares abstained.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the reporting of the stockholder vote results.
Investor Verification Checklist
- Verify the term expiration for the newly elected Class II directors (Matthew M. Jenusaitis and Robert Berman), which is set for the 2022 annual meeting.
- Confirm the significant number of shares withheld for Robert Berman (5,242,605) compared to Matthew M. Jenusaitis (329,589) to understand shareholder sentiment regarding specific board members.
- Review the full proxy statement for the 2019 Annual Meeting to understand the context behind the voting results and any dissenting opinions.
- Check subsequent filings (e.g., 10-K) for the actual financial performance for the fiscal year ending December 31, 2019, as this 8-K does not contain financial data.